Clinical Trials Directory

Trials / Sponsors / I-Mab Biopharma US Limited

I-Mab Biopharma US Limited

Industry · 11 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingGivastomig Combined With Nivolumab and Chemotherapy in Adults With CLDN18.2 Positive Metastatic Gastric Cancer
Solid Tumor, Advanced Cancer, Metastatic Cancer
Phase 22026-02-01
UnknownA Study Evaluating TJ210001 in the Treatment of Subjects With Advanced Solid Tumors
Advanced Solid Tumor
Phase 12023-12-31
CompletedA Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid
Ovarian Cancer, Head and Neck Cancer, Non Small Cell Lung Cancer
Phase 22021-11-02
RecruitingStudy of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Solid Tumor, Advanced Cancer, Metastatic Cancer
Phase 12021-06-29
CompletedStudy of TJ210001 Administered in Subjects With Relapsed or Refractory Advanced Solid Tumors
Solid Tumor, Metastatic Cancer, Advanced Cancer
Phase 12020-12-17
UnknownA Study of TJ003234 in Rheumatoid Arthritis Patients
Rheumatoid Arthritis
Phase 12020-08-06
CompletedStudy of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19
Coronavirus Disease 2019 COVID-19
Phase 2 / Phase 32020-04-11
CompletedStudy of TJ011133 in Participants With Relapsed/Refractory Advanced Solid Tumors and Lymphoma
Solid Tumor, Lymphoma
Phase 12019-04-16
CompletedStudy of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Healthy Adult Subjects
Healthy Adult Subjects
Phase 12019-03-18
No Longer AvailableExpanded Access Study of TJ004309 in Patients With Advanced or Metastatic Cancer
Cancer
——
No Longer AvailableExpanded Access Protocol for Subjects With Relapsed or Refractory Advanced Solid Tumors Receiving TJ210001
Solid Tumor Metastatic Cancer Advanced Cancer
——